Demand for animal models is anticipated for the increase at a CAGR of 6%. The industry had a value of US$ 1.6 billion as of 2021, and in 2022 it is anticipated to expand at a Y-o-Y growth rate of 6.2%, reaching US$ 2.9 Billion by 2032
The key forces driving market expansion are an increase in clinical trials and improved funding for this research. The European Medicine Agency reports that there are currently 37,293 clinical studies registered in Europe as of the year 2020. Additionally, according to the World Health Organisation, there were around 92% of registered trials in South East Asia in 2019 and approximately 66% in the Eastern Mediterranean region.
Download Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=1590?AS
Key Takeaways from Cat Model Market Study
- By 2022, Fact.MR expected demand for Animal Modesto reach US$ 1.7 Billion
- By 2032, the market for Animal Models likely to be valued at US$ 2.9 Billion
- China is expected to register a 5.7% CAGR with regard to the Animal Model industry
- Japan is expected to document a CAGR worth 4.5% in the Animal Model market
- Academic and research institutions are anticipated to grow at a CAGR of 6% over the assessment period.
- Rat-based animal models to yield a revenue share of around 40% in 2022 and beyond.
Competitive Landscape
As a result of the increasing demand for animal models, the market players make continual strategic developments in order to exceed the competition, thus fueling the rise of the animal model market. Some key developments are as follows:
- In April 2022, Taconic Biosciences and Biomodels collaborated to initiate the Taconic-Biomodels Microbiome Initiative (TBMI), providing investigators with seamless access to complete germ-free and gnotobiotic microbiome study solutions, from design to data. The solutions helps eliminate hurdles which have long limited microbiome research by combining access to relevant disease models, germ-free animal production, and downstream in-vivo research design, execution, and analytics.
- In September 2021, Inotiv Inc. and Envigo announced an agreement wherein the former has agreed to purchase the latter. With this acquisition, both companies will be able to better access products and services for the entirety of discovery and non-clinical development within one organization.
Key players in the Monkey Model Market
- Genoway SA
- Eurofins Scientific SE
- Crown Bioscience Inc.
- Envigo CRS SA
- Transposagen Biopharmaceuticals, Inc.
- Trans Genic Inc.
- The Jackson Laboratory
- Horizon Discovery Group Plc.
- Charles River Laboratories International Inc.
Market Trends
Here are some trends that were observed in the animal model market:
- Increasing Demand: The demand for animal models has been steadily increasing over the years. Animal models are widely used in biomedical research, drug development, and testing for various diseases, which has fueled their demand.
- Rising Prevalence of Chronic Diseases: The increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders has contributed to the demand for animal models. Researchers use animal models to study the disease mechanisms, test potential treatments, and evaluate the safety and efficacy of new drugs.
- Technological Advancements: Advances in genetic engineering and gene-editing technologies, such as CRISPR/Cas9, have significantly enhanced the capabilities of animal models. These technologies enable the creation of more precise and sophisticated animal models, allowing researchers to mimic human diseases more accurately.
- Shift Towards Humanized Models: There has been a growing emphasis on developing humanized animal models that closely mimic human physiology and disease conditions. Humanized models, such as mice with a human immune system or patient-derived xenograft models, are valuable for studying human-specific diseases and testing personalized therapies.
- Ethical Considerations: Animal welfare concerns and the push for alternatives to animal testing have prompted researchers to explore alternative models, such as in vitro cell culture and organ-on-a-chip systems. While these alternatives may not fully replace animal models, they are gaining attention and may impact the future landscape of the animal model market.
- Increased Regulatory Scrutiny: The use of animal models in research and drug development is subject to strict regulations to ensure ethical treatment and minimize unnecessary animal testing. Regulatory agencies are placing greater emphasis on the use of alternative methods and the refinement of animal models, which may influence the market dynamics.
- Collaborations and Partnerships: Collaborations between academic institutions, pharmaceutical companies, and contract research organizations (CROs) are becoming more prevalent in the animal model market. These partnerships facilitate knowledge sharing, access to specialized expertise, and resource pooling, leading to accelerated research and development.
- Growing Focus on Rare Diseases: With advancements in precision medicine and the increasing recognition of rare diseases, there is a growing demand for animal models that can mimic these specific conditions. Animal models play a crucial role in understanding the underlying mechanisms of rare diseases and developing targeted therapies.
Get Customization on Rabbit Model Market Report for Specific Research Solutions
https://www.factmr.com/connectus/sample?flag=RC&rep_id=1590?AS
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Email : [email protected]